These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28936754)

  • 1. Biomarker Discovery in Parkinson's Disease: Present Challenges and Future Opportunities.
    Li S; Le W
    Neurosci Bull; 2017 Oct; 33(5):481-482. PubMed ID: 28936754
    [No Abstract]   [Full Text] [Related]  

  • 2. Biomarkers of Parkinson's disease: current status and future perspectives.
    Wang J; Hoekstra JG; Zuo C; Cook TJ; Zhang J
    Drug Discov Today; 2013 Feb; 18(3-4):155-62. PubMed ID: 22982303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarker promise for Parkinson's disease.
    The Lancet Neurology
    Lancet Neurol; 2010 Dec; 9(12):1139. PubMed ID: 21087732
    [No Abstract]   [Full Text] [Related]  

  • 4. DJ-1 as a Biomarker of Parkinson's Disease.
    Saito Y
    Adv Exp Med Biol; 2017; 1037():149-171. PubMed ID: 29147908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass spectrometry: A platform for biomarker discovery and validation for Alzheimer's and Parkinson's diseases.
    Cilento EM; Jin L; Stewart T; Shi M; Sheng L; Zhang J
    J Neurochem; 2019 Nov; 151(4):397-416. PubMed ID: 30474862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers in Parkinson's disease: Advances and strategies.
    Delenclos M; Jones DR; McLean PJ; Uitti RJ
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1(Suppl 1):S106-10. PubMed ID: 26439946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkinson's disease biomarkers: perspective from the NINDS Parkinson's Disease Biomarkers Program.
    Gwinn K; David KK; Swanson-Fischer C; Albin R; Hillaire-Clarke CS; Sieber BA; Lungu C; Bowman FD; Alcalay RN; Babcock D; Dawson TM; Dewey RB; Foroud T; German D; Huang X; Petyuk V; Potashkin JA; Saunders-Pullman R; Sutherland M; Walt DR; West AB; Zhang J; Chen-Plotkin A; Scherzer CR; Vaillancourt DE; Rosenthal LS
    Biomark Med; 2017 May; 11(6):451-473. PubMed ID: 28644039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of Metabolomics-Based Biomarker Research for Parkinson's Disease.
    Li X; Fan X; Yang H; Liu Y
    Mol Neurobiol; 2022 Feb; 59(2):1041-1057. PubMed ID: 34826053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tears - more to them than meets the eye: why tears are a good source of biomarkers in Parkinson's disease.
    Edman MC; Janga SR; Kakan SS; Okamoto CT; Freire D; Feigenbaum D; Lew M; Hamm-Alvarez SF
    Biomark Med; 2020 Feb; 14(2):151-163. PubMed ID: 32064896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers for Parkinson's Disease: How Good Are They?
    Li T; Le W
    Neurosci Bull; 2020 Feb; 36(2):183-194. PubMed ID: 31646434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enabling biomarker discovery in Parkinson's disease using multiomics: challenges, promise and the future.
    Kiebish MA; Narain NR
    Per Med; 2019 Jan; 16(1):5-7. PubMed ID: 30422077
    [No Abstract]   [Full Text] [Related]  

  • 12. Emerging targets for the diagnosis of Parkinson's disease: examination of systemic biomarkers.
    Cheslow L; Snook AE; Waldman SA
    Biomark Med; 2021 Jun; 15(8):597-608. PubMed ID: 33988462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers of cognitive decline in Parkinson's disease.
    Lin CH; Wu RM
    Parkinsonism Relat Disord; 2015 May; 21(5):431-43. PubMed ID: 25737398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers in Parkinson's disease: an update.
    Shtilbans A; Henchcliffe C
    Curr Opin Neurol; 2012 Aug; 25(4):460-5. PubMed ID: 22772875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New markers in Parkinson's disease.
    Bougea A
    Adv Clin Chem; 2020; 96():137-178. PubMed ID: 32362317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Updating Our Definitions of Parkinson's Disease for a Molecular Age.
    Chen-Plotkin AS; Zetterberg H
    J Parkinsons Dis; 2018; 8(s1):S53-S57. PubMed ID: 30584165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candidate biomarkers for Parkinson's disease.
    Khodadadian A; Hemmati-Dinarvand M; Kalantary-Charvadeh A; Ghobadi A; Mazaheri M
    Biomed Pharmacother; 2018 Aug; 104():699-704. PubMed ID: 29803930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkinson's disease biomarkers based on α-synuclein.
    Fayyad M; Salim S; Majbour N; Erskine D; Stoops E; Mollenhauer B; El-Agnaf OMA
    J Neurochem; 2019 Sep; 150(5):626-636. PubMed ID: 31265130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers of Parkinson's disease: 20 years later.
    Yilmaz R; Hopfner F; van Eimeren T; Berg D
    J Neural Transm (Vienna); 2019 Jul; 126(7):803-813. PubMed ID: 30949837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autophagic- and Lysosomal-Related Biomarkers for Parkinson's Disease: Lights and Shadows.
    Xicoy H; Peñuelas N; Vila M; Laguna A
    Cells; 2019 Oct; 8(11):. PubMed ID: 31731485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.